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Abstract
Background: DNA microarrays provide data for genome wide patterns of expression between
observation classes. Microarray studies often have small samples sizes, however, due to cost
constraints or specimen availability. This can lead to poor random error estimates and inaccurate
statistical tests of differential expression. We compare the performance of the standard t-test, fold
change, and four small n statistical test methods designed to circumvent these problems. We
report results of various normalization methods for empirical microarray data and of various
random error models for simulated data.
Results: Three Empirical Bayes methods (CyberT, BRB, and limma t-statistics) were the most
effective statistical tests across simulated and both 2-colour cDNA and Affymetrix experimental
data. The CyberT regularized t-statistic in particular was able to maintain expected false positive
rates with simulated data showing high variances at low gene intensities, although at the cost of low
true positive rates. The Local Pooled Error (LPE) test introduced a bias that lowered false positive
rates below theoretically expected values and had lower power relative to the top performers. The
standard two-sample t-test and fold change were also found to be sub-optimal for detecting
differentially expressed genes. The generalized log transformation was shown to be beneficial in
improving results with certain data sets, in particular high variance cDNA data.
Conclusion: Pre-processing of data influences performance and the proper combination of pre-
processing and statistical testing is necessary for obtaining the best results. All three Empirical
Bayes methods assessed in our study are good choices for statistical tests for small n microarray
studies for both Affymetrix and cDNA data. Choice of method for a particular study will depend
on software and normalization preferences.
Background
Microarrays provide large-scale comparative gene expres-
sion profiles between biological samples by detecting dif-
ferential expression for thousands of genes in parallel.
Typically, systematic error (bias) in the measurements is
removed at the background correction and normalization
steps, and is followed by statistical testing. In the most
common type of study, statistical testing produces a list of
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genes that are differentially expressed across two or more
classes (e.g., patient groups, treated vs. control animals,
etc.) [1].
Extensive research has shown that choice of pre-process-
ing methods designed to correct for bias in the measure-
ments can have a substantial impact on rank ordering of
gene expression fold-change (FC) estimates for both
cDNA [2] and oligonucleotide data [3-5] and the Affy-
Comp website [6]. One major disadvantage of FC esti-
mates, however, is that they do not take the variance of the
samples into account. This is especially problematic
because variability in gene expression measurements is
partially gene-specific [7], even after the variance has been
stabilized by data transformation [8].
There is consensus in the statistical community that statis-
tical tests of differential expression are preferred over FC
for inference [9]. One advantage is that they standardize
differential expression by dividing FC measurements by
their associated standard error, rescaling FCs to a common
metric. Moreover, associated output such as p values,
effect sizes, and confidence intervals can be used for vari-
ous purposes such as false positive control [10] and meta-
analysis [11].
Although microarray studies with sample sizes of five or
more observations per class are becoming increasingly
common, cost considerations and the need for small scale
initial studies mean that many studies are conducted with
smaller sample sizes. The use of classical statistical tests
such as the t-test is sub-optimal for small sample studies,
however, because of low statistical power for detection of
differential expression. This has led to the development of
small sample size error estimation methods which borrow
information from the entire data set or from a subset of
the data to improve error estimation accuracy and preci-
sion [9,12].
There has been a number of studies analysing the per-
formance of statistical tests applied to microarray data but
few have used data where the differentially expressed
genes are known in advance. Qin and Kerr [2] compared
normalization methods and test statistics using data sets
with six known differentially expressed genes and showed
that the standard t-statistic performed worse than those
that used variance estimates that incorporated informa-
tion from all genes. Sioson et al. [13] compared statistical
methodologies of two software applications using qRT-
PCR of a subset of genes and Chen et al. [14] used a con-
sensus of differentially expressed genes across statistical
methods to analyze performance. None of these studies,
however, evaluated statistical tests designed for small
sample size experiments.
A number of studies have examined small n tests. Kooper-
berg et al. [15] compared the performances of various 2-
group statistical tests with empirical and simulated data.
Distributions of p-values were generated based on data
from the same experimental group (and consequently it
was known that there were no differences) or data from
different experimental groups which were known to dif-
fer. The high performing tests generated p-value distribu-
tions consistent with a null distribution in the former case
and produced the largest number of small p-values in the
latter case. Using the limma method [16] as an exemplar,
they concluded that an Empirical Bayes approach to statis-
tical testing provided good power while accurately con-
trolling false positive rates for small n microarray
experiments. Cui and Churchill [17] reviewed a number
of statistical tests for use with microarray data, including
one small n test, but provided no comparative analysis.
Tong and Wang [18] used simulated data to explore the
theoretical properties of shrinkage methods of estimating
variance and found that they outperformed tests that use
only the sample variance. Hu and Wright [19] and Xie et
al. [20] both compared a number of statistical tests,
including several small n tests, using a consensus list of
differentially expressed genes from all methods. Hu and
Wright [19] found that, based on false discovery rates,
tests that model the variance/intensity relationship and
use variance estimates generated with information from
all genes performed the best. Xie et al [20] showed that
there was comparability of results for only a few of the
methods but the Lönnstedt and Speed [21] B-statistic,
which is monotonically equivalent to the limma [16] and
BRB [22] t-statistics, had the lowest false positive rate. Jef-
ferey et al. [23] looked at the use of statistical tests, includ-
ing several small n tests, in feature selection for group
classification; the results varied greatly across gene list and
sample size but the Empirical Bayes t-statistic performed
well across all sample sizes. Most of these studies com-
pared methods using comparability of results, estimated
false discovery, family wise error rates, or p-value distribu-
tions to assess performance. In this paper we focus on
each method's ability to detect genes which have been
spiked at different concentrations across samples (i.e.,
which are differentially expressed by design).
We use simulated data, two publicly available empirical
Affymetrix Latin-Square data sets, and two cDNA data sets
in which the differentially expressed genes are known to
assess the relative performances of FC, t-statistic, and four
small sample size statistical tests which all borrow
strength from other genes in different ways. For consist-
ency, we refer to the various tests by their software imple-
mentation. The Local Pooled Error method (LPE) z-
statistic [24] is based on pooling errors for genes with sim-
ilar intensities. The three Empirical Bayes methods were:
the BRB t-statistic [22] which combines gene-specific errorBMC Bioinformatics 2009, 10:45 http://www.biomedcentral.com/1471-2105/10/45
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estimates with a common error estimate obtained from
the distribution of the variances across all genes; the
CyberT regularized t-statistic [25] which combines gene-
specific error estimates with a local pooled error estimate
based on genes with similar intensities; and the limma
method [16] which combines a fitted linear model of
gene expression data with a variance estimate into a mod-
erated t-statistic. All methods gain degrees of freedom
over the standard t-test and in theory should provide
greater sensitivity with no loss in specificity.
Data
Latin Square spike-in data
The HGU133A and HGU95 Latin Square data sets [26] are
based on a 14 × 14 Latin Square design of "spiked-in"
transcripts (14 concentrations per microarray chip × 14
groups) with three replicates for each group. The concen-
trations for the "spiked-in" transcripts were doubled for
each consecutive group (0 and 0.125 to 512 pM inclusive
for HGU133A; 0 and 0.25 to 1024 pM inclusive for
HGU95).
We compared performance of the statistical tests (see
Methods) for detecting two-fold differential expression
after the data had been normalized by six popular expres-
sion summary algorithms: MAS 5.0 [27], dChip [28],
RMA [3], gcRMA [29], VSN [30], and LMGene [31]. Data
were analysed on the log scale for the first four methods
and on a generalized log (glog) scale for the latter two
methods.
cDNA spike-in data
Two spotted cDNA experiments [32] were also used to
compare statistical test performance. The first experiment
compared two aliquots from the same mouse liver RNA
sample, and the second compared one RNA sample from
mouse liver to a pooled sample of five different mouse tis-
sues (liver, kidney, lung, brain, and spleen). In both
experiments six transcripts were "spiked-in" at a three-fold
difference in concentration between the two groups. All
cDNA slides measured each "spike-in" transcript at 48 dif-
ferent well locations for a total of 288 "spikes" in each
experiment.
The data were normalized using the lowess normalization
of LMGene [31], with and without a glog transformation
and background correction (foreground median intensity
minus background median intensity), and the VSN
method [30]. The LMGene lowess normalization method
is equivalent to the intensity-dependent normalization
used in Yang et al. [33]. MvA plots and their correspond-
ing lowess fits for each cDNA array are shown in Addi-
tional file 1.
Simulated data
Two limitations of the above spike-in data sets make them
less challenging than most biologically motivated studies:
variation across technical replicates is lower than that typ-
ically observed across biological replicates [34-36] and
many biological effects of interest may be smaller than
two-fold. Also, there is only a small number of "spiked-in"
transcripts in each Latin Square experiment, which can
lead to increased variability in the algorithm performance
metrics [37]. Simulated data were generated to offset these
limitations: Null hypothesis and "spike-in" data (in which
a subset of the simulated genes were upwardly expressed
in one group) were used to examine false positive rates
(FPR), genes incorrectly labeled as differentially
expressed, and true positive rates (TPR), genes correctly
labeled as differentially expressed. The "spike-in"data
incorporated varying degrees of variability between repli-
cate measurements and genes were differentially
expressed across a range of fold changes to offset the lim-
itations of the Latin Square data sets.
Each simulation experiment consisted of 1000 iterations
of ten thousand genes for each of two groups (control and
treatment) with 3, 4, or 5 replicates per gene. Gene inten-
sity values were generated by randomly selecting from a
N(u, σ2) distribution, where u  is the "true" expression
intensity (drawn from a N(7, 1) distribution) for a single
gene in log2 scale and σ2 is the random error associated
with the gene's expression measurement. In the null
hypothesis data, each gene-specific u  remains constant
across both groups; in the "spike-in" data, μ was upwardly
regulated by a specified fold change for 100 genes in the
treatment group.
For each "spiked-in" gene, μ was assigned a value from a
set of 10 log2 values ranging from 4 to 8.5 in 0.5 incre-
ments. The log2 fold change applied to the "spiked-in
genes" was implemented by an additive adjustment to
their u in the treatment group chosen from a range of 10
values from 0.2 to 1.1 (fold change from 1.15 to 2.15) in
0.1 increments. There are 10 "spiked-in" genes at each of
the 10 concentration values and each of those 10 genes at
a particular concentration value is upwardly regulated by
one of the 10 different fold changes.
The random error of each gene is derived from one of
three variance models: common, inverse gamma, and
local (Table 1). In the common error model, the popula-
tion variance (c) of the random error term () is a constant
across all genes. In the inverse gamma variance model, c is
drawn randomly from an inverse gamma distribution,
IG(3, b), where 3 is the shape parameter and b is the scale
parameter. In the local variance model,  is a combination
of additive (a) and proportional (p) components, as out-
lined in Rocke and Durbin [38].BMC Bioinformatics 2009, 10:45 http://www.biomedcentral.com/1471-2105/10/45
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The parameters of each variance model were varied to cre-
ate data sets from low variance (approximating the Latin
Square and some cell line data sets) to medium and high
variance (approximating the increased variance observed
in experimental animal and patient tissue samples
[34,39]. Scatter plots of expression intensity versus log
pooled variance of the three variance models with high
variance are shown in Figure 1A.
Table 1: Simulated data error models
Variance Model Expression Intensity (xij) Random Error Parameters
Common μi + ii   ~ N (0, c) c ∈ (.1, .05, .01)
Inverse Gamma μi + ii   ~ N (0, IG(3, b)) b ∈ (.2, .1, .05)
Local
log2( +  ai)
ai ~ N (0, c)
pi ~ N (0, .1)
c ∈ (50, 25, 5)
The Expression Intensity column shows how the replicate intensity values were generated for each transcript. The Random Error column shows 
the method of calculating specific  values. The Parameters column shows the values that were used to generate high, medium, and low variances, 
respectively.
μie
pi ∈
Scatter plots of intensity vs log variance and histograms of p values for all methods and data sets Figure 1
Scatter plots of intensity vs log variance and histograms of p values for all methods and data sets. A and B show 
simulated high variance null hypothesis data (n = 6); C and D show HGU133A data with the "spiked-in" genes removed. (A) 
Scatter plot of intensity versus pooled log variance (1 iteration). (B) Histograms of p values (1000 iterations). (C) Scatter plot 
of intensity versus log pooled variance. (D) Histograms of p values (average of all 14 comparisons). Orange columns in histo-
grams correspond to the proportion of p values ≤ 0.05.
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Methods
See Additional file 2 for software versions and availability.
Fold-change
The Fold-Change (FC) ratio is typically represented on the
log2 scale:
where   and   are the means of the two groups' logged
expression values.
Independent t-test
The independent t-statistic provides a standardized esti-
mate of differential expression according to the following
formula:
where
 and ni are the variance and number of replicates for
the ith group, respectively.   is the weighted average of
the two groups gene-specific variance. The associated
probability under the null hypothesis is calculated by ref-
erence to the t distribution with n1 + n2 - 2 degrees of free-
dom.
Local pooled error (LPE) z-statistic
Jain et al.'s (2003) local pooled error test is based on the
model that genes with similar observed intensities have
similar true variances and is calculated as follows:
where
The fold change is calculated using a difference of medi-
ans and the gene specific   is obtained from a calibra-
tion curve derived from pooling the variance estimates of
each gene's replicate expression measures with the vari-
ance estimates of other genes with similar expression val-
ues. n1 and n2 are the sample sizes for the two groups. The
variance is adjusted by π/2 due to the increased variability
of using medians when calculating the fold change. The
associated probability of the z-statistic under the null
hypothesis is calculated by reference to the standard nor-
mal distribution.
Statistical tests with Empirical Bayes variance estimators
The following three tests use an Empirical Bayes method
to estimate error associated with differential expression
and use a statistical test identical in form to the independ-
ent t-statistic shown in equation 2. The tests use a poste-
rior variance,  , in place of the pooled variance,  ,
in the t-test. Using Bayes rule, the posterior variance,  ,
for each gene becomes a combination of the observed
gene-specific error and an estimate obtained from the
prior distribution according to the following formula.
dg are the degrees of freedom and   are the gene specific
variances obtained from the experimental data. d0 and σ2
are the prior degrees of freedom and variance estimates
respectively [16]. The three methods differ in how they
estimate the parameters d0 and .
Limma t-statistic
Smyth [16] developed the hierarchical model of Lönnst-
edt and Speed [21] into a general linear model that is
more easily applied to microarray data. It is implemented
using the R statistical language in the limma bioconductor
package [40]. This method is based on a model where the
variances of the residuals vary from gene to gene and are
assumed to be drawn from a chi-square distribution.
The linear model is as follows:
E(yg) = Xαg (7)
where yg is the expression summary values for each gene
across all arrays, X is a design matrix of full column rank
and αg is the coefficient vector. The contrasts of coeffi-
cients that are of interest for a particular gene g are defined
as βg = CTαg. Although this approach is able to analyse any
number of contrasts, we examine two sample compari-
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sons only so βg can be defined as the log fold change
 (Equation 1).
The contrast estimators, βg, are assumed to be normal and
the residual variances,  , are assumed to follow a scaled
chi-square distribution. Under this hierarchical model the
posterior variance,  , takes the form:
where d0 and   are the prior degrees of freedom and var-
iance and dg and   are the experimental degrees of free-
dom and the sample variance for a particular gene g,
respectively. Because we examine only two sample com-
parisons, dg will always be equal to n - 2 where n is the
total number of replicates. The two prior parameters, d0
and  , can be interpreted as the degrees of freedom and
variance of the prior distribution respectively. The prior
parameters are estimated by fitting the logged sample var-
iances to a scaled F distribution.
The moderated t-statistic is defined by:
The associated probability of the moderated t-statistic for
the two sample case under the null hypothesis is calcu-
lated by reference to the t-distribution with d0 + dg degrees
of freedom.
BRB t-statistic
Like the limma model, Wright and Simon's [22] RVM t-
statistic, labelled BRB t-statistic after the BRB software,
assumes a random variance model where the variances of
the residuals vary from gene to gene and are random selec-
tions from a single prior inverse gamma distribution,
which is a more general form of the chi-square. The two
models differ, however, in the method of the prior param-
eter estimations. In the BRB model, the estimate of the
gene specific error corresponds to the sample variance of
the gene's replicate expression measures; the prior esti-
mate corresponds to the mean of the inverse gamma prior
distribution fitted to the sample variances. The prior dis-
tribution is P(μ|σ2)P(σ2), where the marginal P(σ2) is the
scaled inverse gamma and the conditional distribution
P(μ|σ2) is normal. That is, the random error associated
with each gene's measurement is assumed to be distrib-
uted normally with a mean of zero and the variance of the
intensity distribution is assumed to be randomly drawn
from a prior inverse gamma distribution whose parame-
ters need to be estimated. The posterior variance for each
gene is a weighted average of its observed sample variance
and the mean of the prior variance distribution. The shape
(a) and scale (b) parameters for the prior are estimated by
fitting the entire collection of observed variances to an
inverse gamma distribution. Rocke [41] has discussed a
method of moments approach to estimate the parameters
while Wright and Simon [22] have advocated a maximum
likelihood approach to fit ab *   to an F(n - k, 2a) dis-
tribution, where n is the total number of replicates and k
is the number of groups. The maximum likelihood
approach was found to have lower variability (data not
shown) and was the method used in this study.
The BRB t-statistic for a particular gene takes the form:
where the posterior variance is
 is the gene specific sample variance with degrees of
freedom of n - 2. The prior variance estimate((ab)-1) is the
mean of the fitted inverse gamma distribution with
degrees of freedom of 2a. The limma prior parameters d0
and   are equivalent to the BRB prior parameters 2a and
(ab)-1. A large number of replicates will give increased
weight to the observed variance while a high value for a
gives increased weight to the prior variance. A large a
means that the inverse gamma is highly peaked making it
more likely that the true variance for any particular gene is
close to (ab)-1. In the two-sample case, the associated
probability of the t-statistic under the null hypothesis is
calculated by reference to the t-distribution with n - 2 + 2a
degrees of freedom.
CyberT t-statistic
The Baldi and Long [25] regularized t-statistic, labelled the
CyberT statistic after the Cyber-T software, combines ele-
ments of both the LPE and the two previous Empirical
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Bayes methods. Like LPE, variance estimates are obtained
by pooling across genes with similar intensities.
A gene specific running average of the variance is used for
the prior variance estimate. The running average variance
is calculated by averaging the variance of a particular gene
and the variances of the z number of genes on either side
of that gene in the ordered distribution. The total window
size (w) for the running average is equal to 2z + 1. Accord-
ingly, for pair, (xi, ),  ordered  by  xi, the running average
is generated using:
The degrees of freedom (v0) for the running average is a
user supplied theoretical value based on the belief in the
quality of the running average variance. The heuristic sug-
gested by Baldi and Long [25] of using three times the
number of replicates was used for the running average
degrees of freedom in the present study.
The CyberT t-statistic takes the form:
where the posterior variance is
 and   are the sample means of the two groups.   is
the gene specific sample variance, n is the total number of
replicates (n1 + n2) per gene across treatment classes, vo is
the degrees of freedom of the prior, and   is the gene
specific running average variance. The associated proba-
bility of the t-statistic under the null hypothesis is calcu-
lated by reference to the t-distribution with n  - 2 + v0
degrees of freedom.
Results and discussion
Descriptive comparisons
Figures 1A and 1C show the scatter plots of log pooled var-
iance estimates (Equations 3, 5, 8, 11, and 14) versus aver-
age intensity across replicates of both groups for
simulated and Affymetrix data, respectively. The t-statistic
shows the unadjusted variance values before the small n
methods are applied and can be used as a baseline for
comparison. The scatter plots for the complete set of Latin
Square comparisons and the null hypothesis data with
low and medium variances are comparable to these plots
(data not shown). With two exceptions (both with MAS
5.0) the four small n statistical tests reduced the variability
of the pooled variance estimates relative to the unadjusted
estimates of the t-test for all data sets; the range of points
on the y-axis in Figures 1A and 1C is diminished along the
smoothing curve. LPE in particular compressed the vari-
ance because the gene-specific variance estimates for each
group are generated from a calibration function, which
maps a single associated variance value per group to each
intensity value. The pooled variance estimates of the BRB
and limma method with the Latin Square data normal-
ized by MAS 5.0 showed little compression. The degrees of
freedom (n - 2 = 4) assigned to the gene-specific variance
is much greater than the degrees of freedom (2a and d0)
assigned to the prior variance estimate (1.2 and 1.4 for
BRB and limma, respectively). Consequently the adjust-
ment applied by the BRB method is negligible. In contrast,
the degrees of freedom values for the data shown in Figure
1 for RMA, gcRMA, dChip, VSN, and LMGene were 6.8,
2.6, 3.8, 256, and 218 for BRB and 5.3, 2.6, 3.3, 5.8, and
9.16 for limma, respectively.
The BRB and limma methods produced similar results for
all expression summary methods with the exception of
the Affymetrix data normalized with VSN and LMGene
which use a generalized log transformation. Although the
BRB and limma methods generated similar prior variance
parameters, the former generated much higher prior
degrees of freedom than the latter. The BRB prior degrees
of freedom were on average 17 times higher than the
limma degrees of freedom (236 to 14) for the VSN expres-
sion summary method and 38 times higher (278 to 7.5)
for the LMGene expression summary method. For these
data, the degrees of freedom for the sample variance were
4 so the posterior variance of the BRB method, which is a
weighted average of the prior and sample variance, devi-
ates only slightly from the prior variance across gene spe-
cific intensity (Figure 1C). The LMGene and VSN
normalization methods both produced a narrow peaked
sample variance distribution consisting of very small var-
iances which will cause the BRB prior degrees of freedom
parameter to be excessively large. The limma prior degrees
of freedom parameter has a more appropriate value
because it is calculated using the log of the sample vari-
ances which do not show such a narrow distribution [see
Additional file 3]. The BRB t-statistic may not be appropri-
ate for LMGene and VSN normalized data due to this
issue.
Figures 1B and 1D show histograms of the p value distri-
butions of the simulated and HGU133A data, respec-
tively. Under the null hypothesis, the distribution of the p
values should follow a uniform distribution. Deviation
from a uniform distribution indicates lack of correspond-
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ence between the data and the assumptions of the statisti-
cal model. The histograms for the complete set of Latin
Square experiments and the null hypothesis data with low
and medium variances are comparable to these plots
(data not shown).
The p value distributions for the t-statistic, BRB t-statistic
and the limma moderated t-statistic followed the theoret-
ically expected uniform distribution for all simulation
models; the CyberT t-statistic deviated slightly from uni-
formity (Figure 1B). For the HGU133A data, all expres-
sion summary methods and statistical tests, with the
exception of LPE, showed a rightward skew in their p
value distributions and a greater than expected number of
small p values (Figure 1D). Unlike the other statistical
tests, the p value distribution for the LPE z-statistic devi-
ated substantially from uniformity for all data sets and
expression summary methods.
Performance
A standard method of comparing the performance of dif-
ferent statistical methods is to use a partial AUC of an
ROC graph calculated using only the lower end of the
ordered distributions of p values. The pAUC has a value
between 0 (worst performance) and 1 (perfect perform-
ance). These metrics were calculated for each of the 1000
iterations of the simulated "spike-in" data sets and for the
14 comparisons of each of the two Latin Square data sets.
A particular false positive rate that applies commonly
across the different distributions is often chosen. This has
the advantage of ensuring that the same number of data
points are used in the comparison but has the disadvan-
tage that it ignores the actual p values of the data points
being compared. An alternative is to use a cutoff based on
a specific p value rather than using only the rankings
which is more in line with how the test results would be
used in applied contexts. We present results for the latter
below and for the former in Additional file 4.
The average pAUC scores and rankings for all methods
and data sets are shown in Table 2. The average true and
false positive rates are shown in Tables 3 and 4 respec-
tively.
Figure 2 shows the boxplots of the pAUC of the statistical
tests and FC for the "spike-in" high variance simulated
data and for the two Latin Square data sets. For the simu-
lated data, the CyberT, BRB, and limma tests consistently
outperformed both the LPE and t-test methods. The pat-
tern of results for the low and medium variance simulated
data was the same as for the high variance simulated data,
although, as expected, the effects were less pronounced
[see Additional file 5]. All statistical tests performed simi-
larly well for both Affymetrix Latin Square data sets, lend-
ing support to our argument that technically replicated
data sets do not provide sufficient challenges for rigorous
algorithm comparisons.
The three Empirical Bayes variance estimation methods,
CyberT, BRB, and limma, performed comparably to FC
with almost all low variance data sets (Table 2). They
appreciably outperformed FC, however, with the liver ver-
sus pooled cDNA data set, which is characterized by
higher variance than the other data sets due to the use of
mRNA from multiple tissues, and MAS 5.0 normalized
Latin Square data, which also has higher variability than
the other normalization methods (Figures 1A and 1C).
Greater variability randomly introduces a higher number
of large fold changes between groups simply because of
the greater range of expression intensities across replicate
values. FC, which ignores variability, is less able to sepa-
rate the higher number of random effects from the
"spiked-in" effects than those methods that take the vari-
ability into account. For these latter data, the Empirical
Bayes variance estimation tests of the loess/glog trans-
formed data performed especially well (with or without
background correction). These results show the limita-
tions of using FC with highly variable data [36,42].
Based on average ranks, the CyberT t-statistic, BRB t-statis-
tic, and the limma moderated t-statistic performed best
across all data sets (Table 2). The top performers with the
Latin Square data were able to find almost all of the differ-
entially expressed genes and had comparable pAUC
scores. The three Empirical Bayes variance estimation tests
were in the top four performers with the low variability
liver3 versus liver5 cDNA data and the top three with the
higher variability liver versus pooled cDNA data. For the
simulated data, the limma t-statistic performed best with
the local variance model, tied with the CyberT t-statistic
and the BRB t-statistic for the inverse gamma variance
model, and tied with FC and the BRB t-statistic for best
performance for the common variance model. The t-statis-
tic and LPE z-statistic were the worst performers overall.
These results are similar to those generated by the pAUCs
with the same number of data points across tests [see
Additional file 4]. In both cases, the average performances
of the three Empirical Bayes tests were ranked in the top
three, FC was ranked fourth, and the LPE and t-test were
ranked last [see Additional file 6].
Figure 3 shows the pAUC of the methods for each of the
10 different fold changes of the spikes with the inverse
gamma simulated data across the 1000 simulation itera-
tions. There are ten "spiked-in" genes at different concen-
trations at each of the 10 different fold changes. The FC,
CyberT, BRB, and limma methods did comparably well at
high fold changes and comparably poorly at low fold
changes. The FC method performed poorly relative to theBMC Bioinformatics 2009, 10:45 http://www.biomedcentral.com/1471-2105/10/45
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three Empirical Bayes tests, however, within the middle
FC range (log2 0.4–0.9). Moreover, the LPE's performance
was worse than the other methods at all but the two high-
est FCs, for which the t-test performed worst.
With the common variance model, the high fold change
transcripts were the most easily identified by all methods
and it was within the medium fold change range that
there was the best differentiation between the methods;
this was also seen with lesser effect with the local variance
model (data not shown).
Concentration effects
We examined the data in greater detail by analyzing the
true positive rates (TPR) and the false positive rates (FPR)
separately, conditioned on spike-in concentration and
using a p < 0.05 threshold.
Table 2: pAUC scores
t-stat CyberT LPE BRB limma FC median pAUC
HGU133A MAS 5.0 5 (.68) 1 (.75) 4 (.69) 2.5 (.70) 2.5 (.70) 6 (.18) .70
RMA 6 (.74) 1.5 (.85) 4.5 (.83) 1.5 (.85) 4.5 (.83) 1 (.84) .84
gcRMA 6 (.74) 1.5 (.85) 3 (.83) 4.5 (.79) 4.5 (.79) 1.5 (.85) .81
dChip 4 (.80) 2 (.83) 5 (.78) 2 (.83) 2 (.83) 6 (.76) .82
LMGene 6 (.75) 2.5 (.85) 2.5 (.85) 1 (.88) 4.5 (.84) 4.5 (.84) .85
VSN 6 (.74) 2.5 (.84) 5 (.82) 1 (.86) 2.5 (.84) 4 (.83) .84
avg. rank 5.5 1.8 4 2.1 2.4 4.2
HGU95 MAS 5.0 3 (.59) 1 (.73) 2 (.63) 4.5 (.44) 4.5 (.44) 6 (.10) .52
RMA 6 (.68) 1 (.85) 1.5 (.73) 2.5 (.84) 2.5 (.84) 4 (.83) .84
gcRMA 6 (.76) 1.5 (.91) 5 (.81) 3.5 (.88) 3.5 (.88) 1.5 (.91) .88
dChip 5 (.73) 3 (.82) 6 (.52) 1.5 (.83) 1.5 (.83) 4 (.80) .81
LMGene 5.5 (.74) 1 (.86) 5.5 (.74) 4 (.84) 2.5 (.85) 2.5 (.85) .85
VSN 5.5 (.57) 4 (.76) 5.5 (.57) 2.5 (.80) 2.5 (.80) 1 (.82) .78
avg. rank 5.2 1.9 4.8 3.1 2.8 3.2
cDNA liver vs liver Loess 5 (.78) 4 (.88) 6 (.65) 2.5 (.96) 2.5 (.96) 1 (.97) .92
Loess(BC) 3.5 (.85) 1 (.96) 5 (.80) 3.5 (.85) 2 (.86) 6 (.66) .85
glog Loess 5 (.79) 2 (.96) 6 (.62) 3.5 (.95) 3.5 (.95) 1 (.98) .95
glog Loess(BC) 5 (.81) 1 (.96) 6 (.75) 4 (.93) 3.5 (.93) 3.5 (.94) .93
VSN 5 (.77) 3 (.96) 6 (.61) 3 (.96) 3 (.96) 1 (.97) .96
avg. rank 4.7 2.2 5.8 3.2 2.9 2.2
cDNA liver vs pool Loess 4 (.29) 3 (.39) 6 (.16) 1 (.44) 2 (.43) 5 (.17) .51
Loess(BC) 2.5 (.09) 2.5 (.09) 5 (.05) 2.5 (.09) 2.5 (.09) 6 (.02) .09
glog Loess 4 (.62)) 1 (.73) 5 (.56) 2.5 (.69) 2.5 (.69) 6 (.08) .65
glog Loess(BC) 4 (.62) 1 (.73) 5 (.58) 3 (.65) 2 (.66) 6 (.06) .64
VSN 4 (.50) 1 (.57) 5 (.38) 2.5 (.55) 2.5 (.55) 6 (.05) .53
avg. rank 3.7 1.7 5.2 2.3 2.3 5.8
Simulated Common 6 (.32) 4 (.53) 5 (.42) 2 (.54) 2 (.54) 2 (.54) .54
Local 6 (.15) 4 (.27) 5 (.16) 2 (.60) 1 (.61) 3 (.31) .29
Inverse Gamma 5 (.39) 2 (.53) 6 (.35) 2 (.53) 2 (.53) 4 (.48) .51
avg. rank 5.7 3.3 5.3 2.2 1.2 3.3
total avg. rank 5.0 2.2 5.0 2.6 2.3 3.7
Rankings from best to worst (1 to 5) of average pAUC scores (using a threshold of 0.05) of the six tests of differential expression. The average 
pAUC for each score is in parentheses. The LMGene package was used to apply the Loess normalization and glog transformation to the cDNA 
data. BC indicates that background correction was applied to the data before normalization.BMC Bioinformatics 2009, 10:45 http://www.biomedcentral.com/1471-2105/10/45
Page 10 of 18
(page number not for citation purposes)
The differential expression tests found most of the Latin
Square "spiked-in" genes at the mid to high concentra-
tions with the HGU133A data (Figure 4A). There was,
however, a drop in the TPR at low concentrations found
across all combinations of expression summary methods
and differential expression tests. FC had a very low TPR
across all concentrations with the MAS 5.0 data. The
CyberT, BRB, and limma tests performed as well or better
than the LPE and t-test methods in limiting this effect. For
the simulated local variance model, the BRB t-statistic and
limma moderated t-statistic yielded substantially higher
TPR values across all concentration levels, although there
was a decrease in the TPR among low concentrations for
all statistical tests (Figure 4B). For the common variance
and inverse gamma simulated models, the BRB t-statistic,
the CyberT t-statistic, the limma moderated t-statistic, and
Table 3: True positive rates
t-stat CyberT LPE BRB limma FC median TPR
HGU133A 42 spikes MAS 5.0 4.5 (.76) 1 (.80) 4.5 (.76) 2.5 (.78) 2.5 (.78) 6 (.30) .77
RMA 6 (.80) 2.5 (.87) 4.5 (.86) 2.5 (.87) 4.5 (.86) 1 (.89) .87
gcRMA 6 (.78) 2 (.88) 3 (.86) 4.5 (.83) 4.5 (.83) 1.5 (.89) .85
dChip 4 (.85) 2.5 (.87) 6 (.83) 1 (.88) 2.5 (.87) 5 (.84) .86
LMGene 6 (.80) 3.5 (.89) 3.5 (.89) 1 (.91) 5 (.88) 2 (.90) .87
VSN 6 (.79) 3 (.87) 5 (.85) 1 (.89) 3 (.87) 3 (.87) .89
avg. rank 6 2.5 4.5 1.8 3.4 2.5
HGU95 12 spikes MAS 5.0 2 (.73) 1 (.80) 3 (.71) 4.5 (.68) 4.5 (.68) 6 (.11) .70
RMA 5 (.82) 2.5 (.88) 6 (.81) 2.5 (.88) 2.5 (.88) 2.5 (.88) .88
gcRMA 6 (.85) 2 (.95) 5 (.89) 4 (.91) 3 (.92) 1 (.96) .92
dChip 5 (.84) 4 (.87) 6 (.66) 2 (.89) 2 (.89) 2 (.89) .88
LMGene 5.5 (.89) 2.5 (.85) 5.5 (.89) 2.5 (.89) 4 (.88) 1 (.90) .89
VSN 5 (.73) 4 (.82) 6 (.66) 2 (.85) 3 (.84) 1 (.86) .83
avg. rank 4.8 2.7 5.3 2.9 3.2 2.3
cDNA liver vs liver 288 spikes Loess 5 (.93) 4 (.95) 6 (.65) 2.5 (.97) 2.5 (.97) 1 (.98) .96
Loess(BC) 5 (.95) 2 (.98) 6 (.88) 2 (.98) 2 (.98) 4 (.97) .98
glog Loess 5 (.88) 3 (.97) 6 (.78) 3 (.97) 3 (.97) 1 (.98) .97
glog Loess(BC) 5 (.93) 3 (.97) 6 (.91) 3 (.97) 3 (.97) 1 (.98) .97
VSN 5 (.89) 2.5 (.98) 6 (.70) 2.5 (.98) 2.5 (.98) 2.5 (.98) .98
avg. rank 5.0 2.9 6 2.6 2.6 1.9
cDNA liver vs pool 288 spikes Loess 4 (.63) 1 (.84) 6 (.39) 2 (.83) 3 (.82) 5 (.48) .73
Loess(BC) 2.5 (.17) 1 (.21) 5 (.12) 4 (.16) 2.5 (.17) 6 (.05) .17
glog Loess 5 (.92)) 1 (.98) 4 (.96) 2.5 (.97) 2.5 (.97) 6 (.18) .97
glog Loess(BC) 5 (.93) 1 (.98) 2 (.97) 3.5 (.96) 3.5 (.96) 6 (.16) .96
VSN 4 (.83) 1 (.97) 5 (.67) 2.5 (.92) 2.5 (.92) 6 (.27) .88
avg. rank 4.1 1.0 4.4 2.9 2.8 5.8
Simulated 100 spikes Common 6 (.48) 2.5 (.63) 5 (.51) 2.5 (.63) 2.5 (.63) 2.5 (.63) .63
Local 5 (.26) 4 (.37) 6 (.24) 2 (.69) 1 (.70) 3 (.42) .40
Inverse Gamma 5 (.54) 2 (.65) 6 (.51) 2 (.65) 2 (.65) 2 (.62) .64
avg. rank 5.1 2.5 5.1 2.5 2.6 3.2
total avg. rank 5.0 2.3 5.1 2.5 2.9 3.1
Rankings from best to worst (1 to 5) of average true positive rate (TPR) scores of the six tests of differential expression. The average TPR for each 
score is in parentheses. The LMGene package was used to apply the Loess normalization and glog transformation to the cDNA data. BC indicates 
that background correction was applied to the data before normalization.BMC Bioinformatics 2009, 10:45 http://www.biomedcentral.com/1471-2105/10/45
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FC yielded similarly high TPRs across all concentrations;
the t-test and the LPE z-test yielded lower TPR values
across all concentrations (data not shown).
The effects of expression intensity on the FPR with the
HGU133A Latin Square data varied across differential
expression tests (Figure 5A). LPE showed a decreasing FPR
at low concentrations, with the exception of the MAS 5.0
data. By contrast, the FPR for the t-statistic and CyberT t-
statistic were more uniform across concentration.
FC showed an unstable FPR across intensity with all nor-
malization methods. The FC FPR curve closely follows the
smoothing curve of pooled variance versus intensity from
Figures 1A and 1C for each normalization method. The FC
FPR increases as the average variability at a particular
intensity is high and decreases where the average variabil-
ity is low. For example, with the HGU133A data normal-
ized with dChip, there are generally many genes with high
variance at low intensities and as the intensity increases
the gene variances tend to decrease. The corresponding
FPR follows a similar curve, with a high FPR for genes with
low intensities and a low FPR for genes with high intensi-
ties. The FC method is unable to distinguish between ran-
dom and biological differences in gene expression when
the variability of the replicate measurements is high.
Table 4: False positive rates
t-stat CyberT LPE BRB limma FC
HGU133A 22258 genes MAS 5.0 .064 .078 .060 .063 .062 .05
RMA .069 .084 .044 .078 .078 .05
gcRMA .050 .079 .031 .060 .061 .05
dChip .093 .115 .081 .105 .105 .05
LMGene .082 .099 .065 .095 .093 .05
VSN .074 .091 .049 .091 .088 .05
HGU95 12614 genes MAS 5.0 .044 .05 .042 .046 .046 .05
RMA .040 .037 .011 .035 .034 .05
gcRMA .009 .018 .003 .017 .018 .05
dChip .043 .041 .003 .040 .040 .05
LMGene .040 .035 .008 .035 .033 .05
VSN .040 .035 .008 .035 .033 .05
cDNA liver vs liver 27648 genes Loess .002 .001 0 .001 .001 .05
Loess(BC) .01 .002 .001 .007 .007 .05
glog Loess .007 .002 0 .002 .002 .05
glog Loess(BC) .014 .008 .001 .011 .012 .05
VSN .006 .001 0 .001 .001 .05
cDNA liver vs pool 27648 genes Loess .138 .135 .034 .151 .151 .05
Loess(BC) .174 .171 .106 .169 .173 .05
glog Loess .233 .238 .151 .251 .252 .05
glog Loess(BC) .233 .235 .158 .238 .240 .05
VSN .244 .249 .183 .251 .252 .05
Simulated 9900 genes Common .048 .048 .032 .046 .047 .05
Local .044 .044 .028 .046 .045 .05
Inverse Gamma .048 .053 .039 .048 .048 .05
Average false positive rates (using a p value threshold of .05) of the six tests of differential expression. The LMGene package was used to apply the 
Loess normalization and glog transformation to the cDNA data. BC indicates that background correction was applied to the data before 
normalization.BMC Bioinformatics 2009, 10:45 http://www.biomedcentral.com/1471-2105/10/45
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The CyberT t-statistic and limma moderated t-statistic also
showed a similar, although weaker, pattern as FC in its
FPR behaviour across concentration. This is due to the
pooling of each gene-specific variance with a single prior
error estimate. Genes with variances higher than the prior
estimate have their variances reduced and genes with low
variances have their variances increased. This causes the
denominator of the t-statistic formula to decrease where
variance is generally high, making it more likely that the
null hypothesis is rejected. The opposite effect will hap-
pen when variance is relatively low. The two tests had a
stable FPR with the VSN and LMGene normalized
HGU133A data as the use of a glog transformation stabi-
lized the variance more effectively across intensity.
For the simulated local variance model, FC, the BRB t-sta-
tistic and limma moderated t-statistic (Figure 5B) showed
a similar tracking of the pooled variance smoothing curve
of Figure 1A. Thus, the limma and BRB tests' superior
pAUC performance (Figure 2A) and higher true positive
rate at low concentrations (Figure 4B) for the local vari-
ance model is mitigated by its high FPR among low con-
centrations; for the local variance model, the t-statistic
and the CyberT t-statistic alone yielded the expected 0.05
false positive rate across all concentrations. The LPE z-sta-
tistic yielded the lowest FPR across all concentrations.
Conclusion
Consistent with the consensus among analysts that "bor-
rowing strength" across genes for estimating differential
expression random error is desirable [9,18,43], the three
Empirical Bayes tests (BRB t-statistic, CyberT t-statistic,
and limma moderated t-statistic) performed best. The t-
statistic and the LPE z-statistic had reduced power in com-
parison. FC was comparable to the three Empirical Bayes
methods with data of low variability (the Latin Square
data with the exception of MAS 5.0 normalization and the
cDNA liver3 versus liver5 data) but performed poorly
Trellis boxplots of pAUC scores Figure 2
Trellis boxplots of pAUC scores. Trellis boxplots of pAUC using a p < 0.05 threshold. (A) Simulated "spike-in" variance 
models with 3, 4 and 5 replicates. (B) Latin Square data: processed with 6 expression summary methods. Differential expres-
sion tests: FC: Fold Change, limma: limma moderated t-statistic, BRB: BRB t-statistic, CyberT: CyberT t-statistic, LPE: LPE z-
statistic, t-stat: t-statistic.BMC Bioinformatics 2009, 10:45 http://www.biomedcentral.com/1471-2105/10/45
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Trellis boxplots pAUC scores by fold change for inverse gamma error model Figure 3
Trellis boxplots pAUC scores by fold change for inverse gamma error model. Inverse Gamma variance model simu-
lated "spike-in" data: Trellis boxplots of pAUC using a p < 0.05 threshold. Results are shown for all "spike-in" log2 fold changes 
(0.2–1.1) separately. Differential expression tests: FC: Fold Change, limma: limma moderated t-statistic, BRB: BRB t-statistic, 
CyberT: CyberT t-statistic, LPE: LPE z-statistic, t-stat: t-statistic.
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True positive rates across concentration Figure 4
True positive rates across concentration. True positive rates across concentration using a p < 0.05 threshold. (A) 
HGU133A Latin Square data. (B) Local variance model "spike-in" simulated data with high variance (n = 3). Differential expres-
sion tests: FC: Fold Change, limma: limma moderated t-statistic, BRB: BRB t-statistic, CyberT: CyberT t-statistic, LPE: LPE z-
statistic, t-stat: t-statistic. The limma and BRB t-statistic produce comparable results and consequently limma's orange line 
often conceals BRB's green line.
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False positive rates across concentration Figure 5
False positive rates across concentration. False positive rates across concentration using a p < 0.05 threshold. Genes are 
partitioned into 20 equal-sized bins ordered on expression intensity; for each bin the FPR is calculated by dividing the number 
of significant genes in the bin by the total number of genes in the bin. (A) HGU133A Latin Square data with "spiked-in" genes 
removed. The dashed line is the expected 0.05 FPR rate. (B) Simulated local variance model null hypothesis data with high var-
iance (n = 3). Differential expression tests: FC: Fold Change, limma: limma moderated t-statistic, BRB: BRB t-statistic, CyberT: 
CyberT t-statistic, LPE: LPE z-statistic, t-stat: t-statistic. The limma and BRB t-statistic produce comparable results and conse-
quently limma's orange line often conceals BRB's green line.
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with data characterized by high variability (the Latin
Square data normalized with MAS 5.0 and the cDNA liver
versus pooled data). This is in accordance with other stud-
ies that have shown the standard t-statistic to be subopti-
mal [2,18-20] and that FC is an inappropriate inferential
test [9].
LPE introduced a bias that caused it to generate fewer false
positives than expected. This bias appears to be due to a
theoretical weakness and an incorrect assumption intrin-
sic to the test as originally proposed. Murie and Nadon
[44] have shown that the adjustment to the LPE standard
error, which depends on an asymptotic proof, is overly
conservative with sample sizes smaller than 100. Moreo-
ver, empirical evidence suggests that the LPE's assumption
of similar error variability for genes of similar expression
intensity is incorrect, which leads the LPE test to overesti-
mate p-values for low variability genes and to underesti-
mate them for high variability genes. Recent
modifications to the test have addressed this issue for
microarray gene expression [45,46] and for mass spec-
trometry proteomics data [47]. Indeed, potential differ-
ences in high and low variability genes between our
studies and that of Kooperberg et al. [15] may explain why
they concluded that the LPE test was overly liberal in con-
trast to our current findings and those of Murie and
Nadon that the test is overly conservative.
An important difference in our study between the CyberT
test and the other two Empirical Bayes tests (BRB and
limma), was that only the former maintained a stable
false positive error rate with data that showed an unstable
variance across intensity, such as the experimental and
local normal simulated data. This suggests that these latter
tests may also generate too many false positives among
some biological data sets which, depending on pre-
processing, often show high variance at low concentra-
tions.
As designed in our simulations and has been argued gen-
erally, however, this variance/intensity relationship is an
artifact of the inappropriate log transformation for low
intensity expression values and the generalized log (glog)
transformation is able to stabilize the error variance across
the entire concentration range [30,48]. The glog transfor-
mation, as implemented with VSN and LMGene, lowers
this potentially high FPR among low abundance tran-
scripts in biological data sets while maintaining a rela-
tively high TPR.
Background correction when applied to cDNA data can
generate negative values which cannot be logged and
requires that the negative data points be either discarded
or set to a loggable value. Moreover, we found, as did Qin
and Kerr [2], that using a log transformation after apply-
ing background correction in conjunction with loess nor-
malization either reduced performance, as with the liver
vs pool data, or had a mixed effect on performance, as
with the liver vs liver data. We recommend the use of a
glog transformation (LMGene) when applying back-
ground correction which can transform negative values
and thus avoids the loss of information. The combination
of glog and loess normalization produced comparable
results for both cDNA data sets with and without back-
ground correction and were amongst the top performers
of all normalization methods. An attractive alternative
might be to use background correction methods which
avoid negative values and stabilize the variance as a func-
tion of intensity as described in Ritchie et al. [49].
The performance of the statistical tests was most similar
using the HGU133A data set. With the exception of MAS
5.0 with FC, all of the statistical tests found most of the
"spiked-in" genes readily, illustrating the limitations of
these empirical data sets for comparing performances of
statistical test as they would be applied in experiments
with biological variation. The HGU133A data set, which
used technical replicates, is comparable to our simulated
data with low variance, where in general the methods do
not show large performance differences. The HGU95 data
had higher variability than the HGU133A data and also
showed greater performance differences between meth-
ods. Most biological experiments will be closer to the
medium and the high variance simulated data sets where
differences in performance are more apparent. The three
Empirical Bayes methods in our study consistently per-
formed well across normalization methods and simulated
data designed to mirror the greater variability that is
observed in most biological experiments. For this reason,
we expect that our results apply beyond the narrow meth-
odological confines of our study. Nonetheless, more
definitive tests of the algorithms' merits will be made pos-
sible by future spike-in experiments which are anticipated
to incorporate biological variability [50]. There is also a
need for a similar comparative study among statistical
tests which are suited to study designs that are more com-
plex than the two-independent sample design in our
study. Two of the approaches we evaluated (limma and
BRB) and at least one other that we did not examine [17]
have more general capabilities suited to this type of com-
parative study.
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